Home » Topics » Medical technology

Medical technology
RSS

Valentis Completes Private Sale Of $29M In Convertible Notes

Nov. 21, 2000

Three Virology Teams Zero In On HIV-Curbing Proteasome Complex; Monkey Protective Trials Imminent

Nov. 21, 2000

Gilead, Roche's Tamiflu OK'd As Prophylaxis For Influenza

Nov. 21, 2000

Seattle Genetics Plans To Raise $75M Via Initial Public Offering

Nov. 21, 2000

Biotech Mergers And Acquisitions Aug. 26-Nov. 14, 2000#

Nov. 20, 2000

Avigen, Bayer Form $60 Alliance For Hemophilia B Gene Therapy

Nov. 20, 2000

Xoma Loses Allergan BPI Deal, Files For $112M Shelf Offering

Nov. 20, 2000

Human Genome Project Opens Doors To Discovery, Therapies

Nov. 20, 2000

Patent Lawyer: Calm Players Best Investor Bets In Bioinformatics

Nov. 20, 2000

NIH Immunologists Demonstrate Protective Salivary Stratagem Of Sand Fly Vectors In

Nov. 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....